UDR | ||
---|---|---|
OUTLOOK RATING 1..100 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | |
PROFIT vs RISK RATING 1..100 | 66 | |
SMR RATING 1..100 | 86 | |
PRICE GROWTH RATING 1..100 | 56 | |
P/E GROWTH RATING 1..100 | 3 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RWR | UDR | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 3 days ago79% | 3 days ago56% |
Momentum ODDS (%) | 3 days ago89% | 3 days ago63% |
MACD ODDS (%) | 3 days ago85% | 3 days ago65% |
TrendWeek ODDS (%) | 3 days ago87% | 3 days ago54% |
TrendMonth ODDS (%) | 3 days ago86% | 3 days ago53% |
Advances ODDS (%) | 5 days ago85% | 20 days ago54% |
Declines ODDS (%) | 3 days ago84% | 3 days ago52% |
BollingerBands ODDS (%) | 3 days ago84% | 3 days ago52% |
Aroon ODDS (%) | 4 days ago81% | 3 days ago52% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASVRX | 9.84 | 0.07 | +0.72% |
American Century Small Cap Value R | |||
VTSMX | 152.62 | 0.67 | +0.44% |
Vanguard Total Stock Mkt Idx Inv | |||
GSLLX | 23.27 | 0.09 | +0.39% |
Goldman Sachs Enhanced U.S. Equity Inv | |||
PDIAX | 22.54 | 0.07 | +0.31% |
Virtus KAR Equity Income A | |||
FIJYX | 31.04 | N/A | N/A |
Fidelity Advisor Biotechnology Z |
A.I.dvisor indicates that over the last year, RWR has been closely correlated with UDR. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if RWR jumps, then UDR could also see price increases.
A.I.dvisor indicates that over the last year, UDR has been closely correlated with EQR. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if UDR jumps, then EQR could also see price increases.